In one tiny town, more than a dozen people were diagnosed with the rare neurodegenerative disease ALS. Why? I n March 2009, ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene planning to initiate the confirmatory Phase 3 RESTORE-ALS tr ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

Neurizon Therapeutics (ASX:NUZ) has shared an update on its preparations for its HEALEY ALS Platform Trial – a multicentre, ...

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Transurban Group Ltd. (TRAUF – ...

A patient with speech loss due to amyotrophic lateral sclerosis (ALS) has regained her ability to communicate her feelings, ...

Materials testing specialist ALS Limited is due to report fiscal 2025 results on May 27, 2025. It has not changed guidance for modest improvement in underlying fiscal 2025 NPAT and dividends, and ...

A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...

Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight ...

Canaccord Genuity analyst Carey MacRury maintained a Buy rating on Altius Minerals (ALS – Research Report) yesterday and set a price target of ...

NCX.V NorthIsle Copper and Gold Inc.

(Reuters) - U.S. Federal Reserve Governor Adriana Kugler said on Friday that rising inflation risks argue for an extended period of steady central bank interest rate policy. “Given the recent ...